APO Research
Talk to an analyst

APO RESEARCH · REPORT

Risperidone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Risperidone Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchRisperidone Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Risperidone Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Risperidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Risperidone Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Risperidone Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Risperidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Risperidone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Risperidone market include Ajanta Pharma, Amneal Pharmaceuticals, Apotex, Aurobindo Pharma, Celltrion, Dr. Reddy's Laboratories, Hikma, Lannett and Luye Pharma Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Risperidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Risperidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Risperidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Risperidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Risperidone Segment by Company

Ajanta Pharma

Amneal Pharmaceuticals

Apotex

Aurobindo Pharma

Celltrion

Dr. Reddy's Laboratories

Hikma

Lannett

Luye Pharma Group

Torrent Pharmaceuticals

Tris Pharma

Janssen (Johnson & Johnson)

Sandoz

Risperidone Segment by Type

Tablet

Oral Solution

Risperidone Segment by Application

Schizophrenia

Bipolar Disorder

Risperidone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Risperidone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Risperidone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Risperidone significant trends, drivers, influence factors in global and regions.

6. To analyze Risperidone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Risperidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Risperidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Risperidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Risperidone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Risperidone industry.

Chapter 3: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Risperidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Risperidone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Risperidone Industry Trends Table 2. Risperidone Industry Drivers Table 3. Risperidone Industry Opportunities and Challenges Table 4. Risperidone Industry Restraints Table 5. Global Risperidone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Risperidone Revenue Share by Company (2021-2026) Table 7. Global Risperidone Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Risperidone Sales Volume Share by Company (2021-2026) Table 9. Global Risperidone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Risperidone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Risperidone Key Company Manufacturing Base & Headquarters Table 12. Global Risperidone Company, Product Type & Application Table 13. Global Risperidone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Oral Solution Table 19. Global Risperidone Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Risperidone Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Risperidone Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Risperidone Sales Volume Share by Type (2021-2026) Table 23. Global Risperidone Sales Volume Share by Type (2027-2032) Table 24. Global Risperidone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Risperidone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Risperidone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Risperidone Sales Value Share by Type (2021-2026) Table 28. Global Risperidone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Schizophrenia Table 30. Significant Companies of Bipolar Disorder Table 31. Global Risperidone Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Risperidone Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Risperidone Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Risperidone Sales Volume Share by Application (2021-2026) Table 35. Global Risperidone Sales Volume Share by Application (2027-2032) Table 36. Global Risperidone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Risperidone Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Risperidone Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Risperidone Sales Value Share by Application (2021-2026) Table 40. Global Risperidone Sales Value Share by Application (2027-2032) Table 41. Global Risperidone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Risperidone Sales by Region (2021-2026) & (W Units) Table 43. Global Risperidone Sales Market Share by Region (2021-2026) Table 44. Global Risperidone Sales by Region (2027-2032) & (W Units) Table 45. Global Risperidone Sales Market Share by Region (2027-2032) Table 46. Global Risperidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Risperidone Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Risperidone Sales Value Share by Region (2021-2026) Table 49. Global Risperidone Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Risperidone Sales Value Share by Region (2027-2032) Table 51. Global Risperidone Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Risperidone Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Risperidone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Risperidone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Risperidone Sales by Country (2021-2026) & (W Units) Table 56. Global Risperidone Sales Market Share by Country (2021-2026) Table 57. Global Risperidone Sales by Country (2027-2032) & (W Units) Table 58. Global Risperidone Sales Market Share by Country (2027-2032) Table 59. Global Risperidone Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Risperidone Sales Value Market Share by Country (2021-2026) Table 61. Global Risperidone Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Risperidone Sales Value Market Share by Country (2027-2032) Table 63. Ajanta Pharma Company Information Table 64. Ajanta Pharma Business Overview Table 65. Ajanta Pharma Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ajanta Pharma Risperidone Product Portfolio Table 67. Ajanta Pharma Recent Development Table 68. Amneal Pharmaceuticals Company Information Table 69. Amneal Pharmaceuticals Business Overview Table 70. Amneal Pharmaceuticals Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Amneal Pharmaceuticals Risperidone Product Portfolio Table 72. Amneal Pharmaceuticals Recent Development Table 73. Apotex Company Information Table 74. Apotex Business Overview Table 75. Apotex Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Apotex Risperidone Product Portfolio Table 77. Apotex Recent Development Table 78. Aurobindo Pharma Company Information Table 79. Aurobindo Pharma Business Overview Table 80. Aurobindo Pharma Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Aurobindo Pharma Risperidone Product Portfolio Table 82. Aurobindo Pharma Recent Development Table 83. Celltrion Company Information Table 84. Celltrion Business Overview Table 85. Celltrion Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Celltrion Risperidone Product Portfolio Table 87. Celltrion Recent Development Table 88. Dr. Reddy's Laboratories Company Information Table 89. Dr. Reddy's Laboratories Business Overview Table 90. Dr. Reddy's Laboratories Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Dr. Reddy's Laboratories Risperidone Product Portfolio Table 92. Dr. Reddy's Laboratories Recent Development Table 93. Hikma Company Information Table 94. Hikma Business Overview Table 95. Hikma Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hikma Risperidone Product Portfolio Table 97. Hikma Recent Development Table 98. Lannett Company Information Table 99. Lannett Business Overview Table 100. Lannett Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Lannett Risperidone Product Portfolio Table 102. Lannett Recent Development Table 103. Luye Pharma Group Company Information Table 104. Luye Pharma Group Business Overview Table 105. Luye Pharma Group Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Luye Pharma Group Risperidone Product Portfolio Table 107. Luye Pharma Group Recent Development Table 108. Torrent Pharmaceuticals Company Information Table 109. Torrent Pharmaceuticals Business Overview Table 110. Torrent Pharmaceuticals Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Torrent Pharmaceuticals Risperidone Product Portfolio Table 112. Torrent Pharmaceuticals Recent Development Table 113. Tris Pharma Company Information Table 114. Tris Pharma Business Overview Table 115. Tris Pharma Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Tris Pharma Risperidone Product Portfolio Table 117. Tris Pharma Recent Development Table 118. Janssen (Johnson & Johnson) Company Information Table 119. Janssen (Johnson & Johnson) Business Overview Table 120. Janssen (Johnson & Johnson) Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Janssen (Johnson & Johnson) Risperidone Product Portfolio Table 122. Janssen (Johnson & Johnson) Recent Development Table 123. Sandoz Company Information Table 124. Sandoz Business Overview Table 125. Sandoz Risperidone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Sandoz Risperidone Product Portfolio Table 127. Sandoz Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Risperidone Distributors List Table 131. Risperidone Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Risperidone Product Image Figure 2. Global Risperidone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Risperidone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Risperidone Sales (2021-2032) & (W Units) Figure 5. Global Risperidone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Risperidone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Oral Solution Image Figure 11. Global Risperidone Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Risperidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Risperidone Sales Volume Share by Type (2021-2032) Figure 14. Global Risperidone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Risperidone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Risperidone Sales Value Share by Type (2021-2032) Figure 17. Schizophrenia Image Figure 18. Bipolar Disorder Image Figure 19. Global Risperidone Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Risperidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Risperidone Sales Volume Share by Application (2021-2032) Figure 22. Global Risperidone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Risperidone Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Risperidone Sales Value Share by Application (2021-2032) Figure 25. Global Risperidone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Risperidone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Risperidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Risperidone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Risperidone Sales Value (2021-2032) & (US$ Million) Figure 30. North America Risperidone Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Risperidone Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Risperidone Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Risperidone Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Risperidone Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Risperidone Sales Value (2021-2032) & (US$ Million) Figure 36. South America Risperidone Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Risperidone Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Risperidone Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Risperidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Risperidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Risperidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Risperidone Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Risperidone Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Schizophrenia
  • Bipolar Disorder
Companies covered
  • Ajanta Pharma
  • Amneal Pharmaceuticals
  • Apotex
  • Aurobindo Pharma
  • Celltrion
  • Dr. Reddy's Laboratories
  • Hikma
  • Lannett
  • Luye Pharma Group
  • Torrent Pharmaceuticals
  • Tris Pharma
  • Janssen (Johnson & Johnson)
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Risperidone Sales Value (2021-2032)
  4. 1.2.2 Global Risperidone Sales Volume (2021-2032)
  5. 1.2.3 Global Risperidone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Risperidone Market Dynamics
  1. 2.1 Risperidone Industry Trends
  2. 2.2 Risperidone Industry Drivers
  3. 2.3 Risperidone Industry Opportunities and Challenges
  4. 2.4 Risperidone Industry Restraints
3 Risperidone Market by Company
  1. 3.1 Global Risperidone Company Revenue Ranking in 2025
  2. 3.2 Global Risperidone Revenue by Company (2021-2026)
  3. 3.3 Global Risperidone Sales Volume by Company (2021-2026)
  4. 3.4 Global Risperidone Average Price by Company (2021-2026)
  5. 3.5 Global Risperidone Company Ranking (2024-2026)
  6. 3.6 Global Risperidone Company Manufacturing Base and Headquarters
  7. 3.7 Global Risperidone Company Product Type and Application
  8. 3.8 Global Risperidone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Risperidone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Risperidone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Risperidone Market by Type
  1. 4.1 Risperidone Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Solution
  4. 4.2 Global Risperidone Sales Volume by Type
  5. 4.2.1 Global Risperidone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Risperidone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Risperidone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Risperidone Sales Value by Type
  9. 4.3.1 Global Risperidone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Risperidone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Risperidone Sales Value Share by Type (2021-2032)
5 Risperidone Market by Application
  1. 5.1 Risperidone Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Bipolar Disorder
  4. 5.2 Global Risperidone Sales Volume by Application
  5. 5.2.1 Global Risperidone Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Risperidone Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Risperidone Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Risperidone Sales Value by Application
  9. 5.3.1 Global Risperidone Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Risperidone Sales Value by Application (2021-2032)
  11. 5.3.3 Global Risperidone Sales Value Share by Application (2021-2032)
6 Risperidone Regional Sales and Value Analysis
  1. 6.1 Global Risperidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Risperidone Sales by Region (2021-2032)
  3. 6.2.1 Global Risperidone Sales by Region: 2021-2026
  4. 6.2.2 Global Risperidone Sales by Region (2027-2032)
  5. 6.3 Global Risperidone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Risperidone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Risperidone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Risperidone Sales Value by Region (2027-2032)
  9. 6.5 Global Risperidone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Risperidone Sales Value (2021-2032)
  12. 6.6.2 North America Risperidone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Risperidone Sales Value (2021-2032)
  15. 6.7.2 Europe Risperidone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Risperidone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Risperidone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Risperidone Sales Value (2021-2032)
  21. 6.9.2 South America Risperidone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Risperidone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Risperidone Sales Value Share by Country, 2025 VS 2032
7 Risperidone Country-level Sales and Value Analysis
  1. 7.1 Global Risperidone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Risperidone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Risperidone Sales by Country (2021-2032)
  4. 7.3.1 Global Risperidone Sales by Country (2021-2026)
  5. 7.3.2 Global Risperidone Sales by Country (2027-2032)
  6. 7.4 Global Risperidone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Risperidone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Risperidone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Risperidone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Risperidone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Risperidone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Risperidone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Risperidone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Risperidone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Risperidone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Risperidone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Risperidone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Risperidone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Risperidone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Risperidone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Risperidone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Risperidone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Risperidone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Risperidone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Risperidone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Risperidone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Risperidone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Risperidone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Risperidone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Risperidone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Risperidone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Risperidone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Risperidone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Risperidone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Risperidone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Risperidone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Risperidone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Risperidone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Risperidone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Risperidone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Risperidone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Risperidone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Risperidone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Risperidone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Risperidone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Risperidone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Risperidone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Risperidone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Risperidone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Risperidone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Risperidone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Risperidone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Risperidone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Risperidone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Risperidone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Risperidone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Risperidone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Risperidone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Risperidone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Risperidone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Risperidone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Risperidone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Risperidone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Risperidone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Risperidone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Risperidone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Risperidone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Risperidone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Risperidone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Risperidone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Risperidone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Risperidone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Risperidone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Risperidone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Risperidone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Risperidone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Risperidone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Risperidone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Risperidone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Risperidone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Risperidone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Risperidone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Risperidone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Risperidone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Risperidone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Risperidone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Risperidone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Risperidone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Risperidone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Risperidone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Risperidone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Risperidone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajanta Pharma
  2. 8.1.1 Ajanta Pharma Company Information
  3. 8.1.2 Ajanta Pharma Business Overview
  4. 8.1.3 Ajanta Pharma Risperidone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajanta Pharma Risperidone Product Portfolio
  6. 8.1.5 Ajanta Pharma Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Risperidone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Risperidone Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Apotex
  14. 8.3.1 Apotex Company Information
  15. 8.3.2 Apotex Business Overview
  16. 8.3.3 Apotex Risperidone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Apotex Risperidone Product Portfolio
  18. 8.3.5 Apotex Recent Developments
  19. 8.4 Aurobindo Pharma
  20. 8.4.1 Aurobindo Pharma Company Information
  21. 8.4.2 Aurobindo Pharma Business Overview
  22. 8.4.3 Aurobindo Pharma Risperidone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Aurobindo Pharma Risperidone Product Portfolio
  24. 8.4.5 Aurobindo Pharma Recent Developments
  25. 8.5 Celltrion
  26. 8.5.1 Celltrion Company Information
  27. 8.5.2 Celltrion Business Overview
  28. 8.5.3 Celltrion Risperidone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Celltrion Risperidone Product Portfolio
  30. 8.5.5 Celltrion Recent Developments
  31. 8.6 Dr. Reddy's Laboratories
  32. 8.6.1 Dr. Reddy's Laboratories Company Information
  33. 8.6.2 Dr. Reddy's Laboratories Business Overview
  34. 8.6.3 Dr. Reddy's Laboratories Risperidone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dr. Reddy's Laboratories Risperidone Product Portfolio
  36. 8.6.5 Dr. Reddy's Laboratories Recent Developments
  37. 8.7 Hikma
  38. 8.7.1 Hikma Company Information
  39. 8.7.2 Hikma Business Overview
  40. 8.7.3 Hikma Risperidone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Risperidone Product Portfolio
  42. 8.7.5 Hikma Recent Developments
  43. 8.8 Lannett
  44. 8.8.1 Lannett Company Information
  45. 8.8.2 Lannett Business Overview
  46. 8.8.3 Lannett Risperidone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lannett Risperidone Product Portfolio
  48. 8.8.5 Lannett Recent Developments
  49. 8.9 Luye Pharma Group
  50. 8.9.1 Luye Pharma Group Company Information
  51. 8.9.2 Luye Pharma Group Business Overview
  52. 8.9.3 Luye Pharma Group Risperidone Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Luye Pharma Group Risperidone Product Portfolio
  54. 8.9.5 Luye Pharma Group Recent Developments
  55. 8.10 Torrent Pharmaceuticals
  56. 8.10.1 Torrent Pharmaceuticals Company Information
  57. 8.10.2 Torrent Pharmaceuticals Business Overview
  58. 8.10.3 Torrent Pharmaceuticals Risperidone Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Torrent Pharmaceuticals Risperidone Product Portfolio
  60. 8.10.5 Torrent Pharmaceuticals Recent Developments
  61. 8.11 Tris Pharma
  62. 8.11.1 Tris Pharma Company Information
  63. 8.11.2 Tris Pharma Business Overview
  64. 8.11.3 Tris Pharma Risperidone Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Tris Pharma Risperidone Product Portfolio
  66. 8.11.5 Tris Pharma Recent Developments
  67. 8.12 Janssen (Johnson & Johnson)
  68. 8.12.1 Janssen (Johnson & Johnson) Company Information
  69. 8.12.2 Janssen (Johnson & Johnson) Business Overview
  70. 8.12.3 Janssen (Johnson & Johnson) Risperidone Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Janssen (Johnson & Johnson) Risperidone Product Portfolio
  72. 8.12.5 Janssen (Johnson & Johnson) Recent Developments
  73. 8.13 Sandoz
  74. 8.13.1 Sandoz Company Information
  75. 8.13.2 Sandoz Business Overview
  76. 8.13.3 Sandoz Risperidone Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sandoz Risperidone Product Portfolio
  78. 8.13.5 Sandoz Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Risperidone Value Chain Analysis
  2. 9.1.1 Risperidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Risperidone Sales Mode & Process
  6. 9.2 Risperidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Risperidone Distributors
  9. 9.2.3 Risperidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst